ASTER’s catch-up logic: HYPE has already flown; it’s still halfway up the mountain
Same sector, two different fates. $HYPE surged to around $98 this week, with its market cap climbing above $20 billion and gaining roughly double over the past year—just one step away from a new all-time high. But for $ASTER , another perpetual contract DEX leader in the same category, the price is still hovering around $0.7, with a market cap of about $2 billion. It remains 70% below its historical high of $2.42.
The gap is right there, and that’s where the imagination for a “catch-up rally” comes from.
First, look at their common ground: both are on-chain perpetual contract trading platforms, built on the big narrative of “decentralized derivatives.” Recently, both trading volume and activity have rebounded.
HYPE’s strength is, in essence, the market assigning a valuation premium to the on-chain trading sector—and that premium hasn’t been fully transmitted to ASTER yet.
Next, consider ASTER’s uniqueness: it benefits from the Binance ecosystem, giving it natural advantages in its user base and liquidity access. Historically, after valuation gaps widen among leaders in the same sector, capital often takes action to “find the undervalued spot.” That’s the most direct capital foundation for the catch-up logic.
However, catch-up doesn’t equal guaranteed upside. Three risks to watch closely: first, the valuation gap may reflect real differences in revenue—HYPE’s protocol revenue and buyback pressure are indeed stronger; second, ASTER has a large circulating supply (about 2.7 billion tokens), so the amount of capital required to drive a rally is larger, meaning its elasticity is naturally weaker than HYPE’s, which has lower float; third, competition among perpetual DEXs is heating up—user migration costs are low, and market share could change hands at any time.
The logic may hold, but it needs to be validated by capital inflows and trading volume. The words “catch-up rally” are always confirmed only after the fact.
The above is only my personal opinion and not any investment advice
Same sector, two different fates. $HYPE surged to around $98 this week, with its market cap climbing above $20 billion and gaining roughly double over the past year—just one step away from a new all-time high. But for $ASTER , another perpetual contract DEX leader in the same category, the price is still hovering around $0.7, with a market cap of about $2 billion. It remains 70% below its historical high of $2.42.
The gap is right there, and that’s where the imagination for a “catch-up rally” comes from.
First, look at their common ground: both are on-chain perpetual contract trading platforms, built on the big narrative of “decentralized derivatives.” Recently, both trading volume and activity have rebounded.
HYPE’s strength is, in essence, the market assigning a valuation premium to the on-chain trading sector—and that premium hasn’t been fully transmitted to ASTER yet.
Next, consider ASTER’s uniqueness: it benefits from the Binance ecosystem, giving it natural advantages in its user base and liquidity access. Historically, after valuation gaps widen among leaders in the same sector, capital often takes action to “find the undervalued spot.” That’s the most direct capital foundation for the catch-up logic.
However, catch-up doesn’t equal guaranteed upside. Three risks to watch closely: first, the valuation gap may reflect real differences in revenue—HYPE’s protocol revenue and buyback pressure are indeed stronger; second, ASTER has a large circulating supply (about 2.7 billion tokens), so the amount of capital required to drive a rally is larger, meaning its elasticity is naturally weaker than HYPE’s, which has lower float; third, competition among perpetual DEXs is heating up—user migration costs are low, and market share could change hands at any time.
The logic may hold, but it needs to be validated by capital inflows and trading volume. The words “catch-up rally” are always confirmed only after the fact.
The above is only my personal opinion and not any investment advice